A network meta-analysis of 29 randomised trials finds that lipid-lowering drug effectiveness in primary cardiovascular prevention varies by baseline risk, ...
A five-center cohort study of 9,828 patients across the Greater Bay Area found PCSK9 inhibitor uptake surged in mainland China ...
A meta-analysis of nine randomised trials involving nearly 68,000 patients shows evolocumab dramatically lowers LDL cholesterol and reduces heart attacks ...
A new meta-analysis in the Journal of Neurology finds that adding PCSK9 inhibitors to statin therapy more than doubled the ...
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!
